BSE · TRABI

Transgene Biotek Ltd.

Sector: Healthcare · ISIN: INE773D01018

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#4,928

of 5,004 stocks

🏆 New peak

▲ 261W

Peak #4,928 · 01 Oct 2026

Operating in Healthcare, Transgene Biotek Ltd. trades at an undemanding earnings multiple, has a subdued return on equity, and has a widely-held ownership base, with promoters at just 24%. Ownership as of Jun 2026.

Market Cap

1.95 Cr

P/E Ratio

11.73

P/B Ratio

0.23

ROE

-19.73%

ROCE

-0.45%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	6.00 L	5.45 L	5.45 L	5.28 L
Net Profit	-38.90 L	-45.70 L	-37.37 L	-38.84 L
EPS	0.05	0.06	0.05	0.05
Operating Profit	-9.95 L	-18.02 L	-10.02 L	-12.41 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

23.64%

Public

76.36%

PUBLIC BREAKDOWN

Individuals

71.88%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs